One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial

Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years

(2010) Eirini Lioudaki et al.   Current Vascular Pharmacology

Safety of the Combination of Intensive Cholesterol-Lowering Therapy with Oral Anticoagulation Medication in Elderly Patients with Atrial Fibrillation

(2009) Morteza Enajat et al.   DRUGS & AGING

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia

(2009) T. Jared Bunch et al.   HEART RHYTHM

Amygdala Volume Marks the Acute State in the Early Course of Depression

(2008) Philip van Eijndhoven et al.   BIOLOGICAL PSYCHIATRY

Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy

(2008) S. Knecht et al.   EUROPEAN HEART JOURNAL

Subjective cognitive failures and hippocampal volume in elderly with white matter lesions

(2008) A.G.W. van Norden et al.   NEUROLOGY

Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

(2008) John J.P. Kastelein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural remodeling in atrial fibrillation

(2008) Domenico Corradi et al.   Nature clinical practice. Cardiovascular medicine